1. Home
  2. AMPG vs ALXO Comparison

AMPG vs ALXO Comparison

Compare AMPG & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitech Group Inc.

AMPG

Amplitech Group Inc.

HOLD

Current Price

$4.02

Market Cap

71.1M

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.48

Market Cap

68.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPG
ALXO
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.1M
68.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AMPG
ALXO
Price
$4.02
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.30
AVG Volume (30 Days)
655.8K
215.6K
Earning Date
11-14-2025
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,571,945.00
N/A
Revenue This Year
$168.18
N/A
Revenue Next Year
$100.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
93.47
N/A
52 Week Low
$1.21
$0.40
52 Week High
$4.89
$2.27

Technical Indicators

Market Signals
Indicator
AMPG
ALXO
Relative Strength Index (RSI) 64.51 57.44
Support Level $3.36 $1.07
Resistance Level $3.90 $1.56
Average True Range (ATR) 0.35 0.13
MACD 0.04 0.03
Stochastic Oscillator 85.22 84.69

Price Performance

Historical Comparison
AMPG
ALXO

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: